The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS):: Long-term follow-up of 100 patients

被引:55
|
作者
Roessle, M.
Siegerstetter, V.
Euringer, W.
Olschewski, M.
Kromeier, J.
Kurz, K.
Langer, M.
机构
[1] Univ Freiburg, Med Klin 2, Freiburg, Germany
[2] Univ Freiburg, Inst Diagnost Radiol, Freiburg, Germany
[3] Univ Freiburg, Dept Med Biometry, Freiburg, Germany
关键词
ascites; Budd-Chiari syndrome; stent graft; transjugular intrahepatic portosystemic shunt; transjugular shunt; variceal bleeding; Viatorr;
D O I
10.1080/02841850600806324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To retrospectively evaluate results and clinical outcome of transjugular intrahepatic portosystemic shunt ( TIPS) after implantation of a polytetrafluoroethylene (PTFE)-covered stent graft. Material and Methods: The stent graft was used in 112 patients with higher risk of primary (i.e. patients with Budd-Chiari syndrome) or secondary shunt failure ( patients with occlusion of a previous uncovered stent), or a complicated TIPS procedure with an imminent technical complication requiring covered stent. Patients were scheduled at 3- to 6-month intervals for duplex-sonographic control of shunt function. Radiological revision was performed in patients with a decrease in shunt function by >25%, primary non-response, or relapse of the index symptom. Results: Twelve patients were lost to follow-up, and 100 patients were followed for 22 +/- 15 months. The actuarial rates of shunt patency were 90, 84, and 74% at 1, 2, and 3 years of follow-up, respectively. Two patients developed early ( within 1 month) and 14 patients late shunt failure. Except for one transient rise in liver enzymes due to outflow obstruction by the stent graft, no technical complications were seen. Primary response to treatment was seen in 97% of patients treated for variceal bleeding and 84% of patients treated for refractory ascites. A relapse of the index symptom was seen in 13% of bleeders and 9% of patients treated for refractory ascites. Conclusion: TIPS created with a PTFE-covered stent graft showed favorable long-term results.
引用
收藏
页码:660 / 666
页数:7
相关论文
共 50 条
  • [21] Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results
    Geeroms, Barbara
    Laleman, Wim
    Laenen, Annouschka
    Heye, Sam
    Verslype, Chris
    van der Merwe, Schalk
    Nevens, Frederik
    Maleux, Geert
    EUROPEAN RADIOLOGY, 2017, 27 (05) : 1795 - 1803
  • [22] Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft
    Luo, Xuefeng
    Zhao, Ming
    Wang, Xiaoze
    Jiang, Mingshan
    Yu, Jiaze
    Li, Xiao
    Yang, Li
    PLOS ONE, 2019, 14 (02):
  • [23] Comparison Study of Doppler Ultrasound Surveillance of Expanded Polytetrafluoroethylene-Covered Stent versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt
    Huang, Qian
    Wu, Xingjiang
    Fan, Xinxin
    Cao, Jianmin
    Han, Jianming
    Xu, Lin
    Li, Ning
    JOURNAL OF CLINICAL ULTRASOUND, 2010, 38 (07) : 353 - 360
  • [24] Transjugular intrahepatic portosystemic shunt (TIPS): Indications and long-term patency
    van Buuren, HR
    ter Borg, PCJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 : 100 - 104
  • [25] Transjugular intrahepatic portosystemic shunt for treatment of ascites: polytetrafluoroethylene-covered stents superior to bare stents
    Kuiper, J. J.
    van Buuren, H. R.
    Pattynama, P. M. T.
    de Man, R. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A69 - A69
  • [26] Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt
    Wannhoff, A.
    Hippchen, T.
    Weiss, C. S.
    Friedrich, K.
    Rupp, C.
    Neumann-Haefelin, C.
    Dollinger, M.
    Antoni, C.
    Stampfl, U.
    Schemmer, P.
    Stremmel, W.
    Weiss, K. H.
    Radeleff, B.
    Katus, H. A.
    Gotthardt, D. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 955 - 965
  • [27] Long-term follow-up: Transjugular intrahepatic portosystemic shunt (TIPS) vs. sclerotherapy (ES) for variceal hemorrhage.
    Kwack, H
    Cello, JP
    Olcott, E
    Koch, J
    Gordon, R
    Rogers, SJ
    Ring, EJ
    GASTROENTEROLOGY, 1999, 116 (04) : A1234 - A1235
  • [28] LONG-TERM FOLLOW-UP-STUDY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS)
    PERON, JM
    ROUSSEAU, H
    VINEL, JP
    MAQUIN, P
    CROIZET, O
    PAYEN, JL
    RAILHAC, N
    PASCAL, JP
    JOFFRE, F
    HEPATOLOGY, 1993, 18 (04) : A102 - A102
  • [29] TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT - A 2-YEAR FOLLOW-UP
    ROSSLE, M
    RICHTER, GM
    NOLDGE, G
    HAAG, K
    VONWEIZSACKER, F
    STASS, M
    FARTHMANN, E
    WENZ, W
    PALMAZ, JC
    DIGESTIVE SURGERY, 1992, 9 (01) : 6 - 12
  • [30] Transjugular intrahepatic portosystemic stent shunt:: Indications and long-term outcome
    Wettstein, M
    Lüthen, R
    Cohnen, M
    von Wrisberg, F
    Mödder, U
    Häussinger, D
    ZENTRALBLATT FUR CHIRURGIE, 2005, 130 (03): : 246 - 249